These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8085379)

  • 1. Murine T-helper cell immune response to recombinant vaccinia-Venezuelan equine encephalitis virus.
    Mathews JH; Kinney RM; Roehrig JT; Barrett AD; Trent DW
    Vaccine; 1994 May; 12(7):620-4. PubMed ID: 8085379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant vaccinia virus/Venezuelan equine encephalitis (VEE) virus protects mice from peripheral VEE virus challenge.
    Kinney RM; Esposito JJ; Mathews JH; Johnson BJ; Roehrig JT; Barrett AD; Trent DW
    J Virol; 1988 Dec; 62(12):4697-702. PubMed ID: 3184276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo.
    Pushko P; Parker M; Ludwig GV; Davis NL; Johnston RE; Smith JF
    Virology; 1997 Dec; 239(2):389-401. PubMed ID: 9434729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved protection against Venezuelan equine encephalitis by genetic engineering of a recombinant vaccinia virus.
    Bennett AM; Lescott T; Phillpotts RJ
    Viral Immunol; 1998; 11(3):109-17. PubMed ID: 9918402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specificity of the murine T helper cell immune response to various alphaviruses.
    Mathews JH; Roehrig JT
    J Gen Virol; 1989 Nov; 70 ( Pt 11)():2877-86. PubMed ID: 2479713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Venezuelan equine encephalitis virus vaccines induce mucosal IgA responses and protection from airborne infection in BALB/c, but not C3H/HeN mice.
    Hart MK; Pratt W; Panelo F; Tammariello R; Dertzbaugh M
    Vaccine; 1997 Mar; 15(4):363-9. PubMed ID: 9141206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant sindbis/Venezuelan equine encephalitis virus is highly attenuated and immunogenic.
    Paessler S; Fayzulin RZ; Anishchenko M; Greene IP; Weaver SC; Frolov I
    J Virol; 2003 Sep; 77(17):9278-86. PubMed ID: 12915543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunogenicity of a recombinant strain of vaccinia virus, expressing a Venezuelan equine encephalomyelitis virus structural protein gene in peroral immunization].
    Sviatchenko VA; Kiselev NN; Ryzhikov AB; Bulychev LE; Mikriukova TP; Netesov SV
    Vopr Virusol; 2000; 45(6):38-41. PubMed ID: 11200645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxic T-cell activity is not detectable in Venezuelan equine encephalitis virus-infected mice.
    Jones LD; Bennett AM; Moss SR; Gould EA; Phillpotts RJ
    Virus Res; 2003 Feb; 91(2):255-9. PubMed ID: 12573505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term humoral and cellular immunity induced by a single immunization with replication-defective adenovirus recombinant vector.
    Juillard V; Villefroy P; Godfrin D; Pavirani A; Venet A; Guillet JG
    Eur J Immunol; 1995 Dec; 25(12):3467-73. PubMed ID: 8566039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humoral, mucosal, and cellular immunity in response to a human immunodeficiency virus type 1 immunogen expressed by a Venezuelan equine encephalitis virus vaccine vector.
    Caley IJ; Betts MR; Irlbeck DM; Davis NL; Swanstrom R; Frelinger JA; Johnston RE
    J Virol; 1997 Apr; 71(4):3031-8. PubMed ID: 9060663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Replication and clearance of Venezuelan equine encephalitis virus from the brains of animals vaccinated with chimeric SIN/VEE viruses.
    Paessler S; Ni H; Petrakova O; Fayzulin RZ; Yun N; Anishchenko M; Weaver SC; Frolov I
    J Virol; 2006 Mar; 80(6):2784-96. PubMed ID: 16501087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Venezuelan equine encephalitis-specific immunoglobulin responses: live attenuated TC-83 versus inactivated C-84 vaccine.
    Engler RJ; Mangiafico JA; Jahrling P; Ksiazek TG; Pedrotti-Krueger M; Peters CJ
    J Med Virol; 1992 Dec; 38(4):305-10. PubMed ID: 1474379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccinia virus recombinants encoding the truncated structural gene region of Venezuelan equine encephalitis virus (VEEV) give solid protection against peripheral challenge but only partial protection against airborne challenge with virulent VEEV.
    Phillpotts RJ; Lescott TL; Jacobs SC
    Acta Virol; 2000 Oct; 44(5):233-9. PubMed ID: 11252667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The duration of humoral postvaccinal and postinfection immunity to the Venezuelan equine encephalomyelitis virus].
    Lukin EP; Chernikova NK
    Vopr Virusol; 1993; 38(2):71-4. PubMed ID: 8059525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel vaccine against Venezuelan equine encephalitis combines advantages of DNA immunization and a live attenuated vaccine.
    Tretyakova I; Lukashevich IS; Glass P; Wang E; Weaver S; Pushko P
    Vaccine; 2013 Feb; 31(7):1019-25. PubMed ID: 23287629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant Isfahan Virus and Vesicular Stomatitis Virus Vaccine Vectors Provide Durable, Multivalent, Single-Dose Protection against Lethal Alphavirus Challenge.
    Nasar F; Matassov D; Seymour RL; Latham T; Gorchakov RV; Nowak RM; Leal G; Hamm S; Eldridge JH; Tesh RB; Clarke DK; Weaver SC
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28148802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IRES-driven expression of the capsid protein of the Venezuelan equine encephalitis virus TC-83 vaccine strain increases its attenuation and safety.
    Guerbois M; Volkova E; Forrester NL; Rossi SL; Frolov I; Weaver SC
    PLoS Negl Trop Dis; 2013; 7(5):e2197. PubMed ID: 23675542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody studies in ponies vaccinated with Venezuelan equine encephalomyelitis (strain TC-83) and other alphavirus vaccines.
    Ferguson JA; Reeves WC; Hardy JL
    Am J Vet Res; 1977 Apr; 38(4):425-30. PubMed ID: 851275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistence in humans of antibody to subtypes of Venezuelan equine encephalomyelitis (VEE) virus after immunization with attenuated (TC-83) VEE virus vaccine.
    Burke DS; Ramsburg HH; Edelman R
    J Infect Dis; 1977 Sep; 136(3):354-9. PubMed ID: 903673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.